Ritonavir



Indications and Reactions:

Role Indications Reactions
Primary
Hiv Infection 46.9%
Product Used For Unknown Indication 18.2%
Drug Use For Unknown Indication 9.5%
Drug Exposure During Pregnancy 9.2%
Antiretroviral Therapy 4.5%
Maternal Exposure Timing Unspecified 3.5%
Hypertension 0.9%
Hepatitis C 0.8%
Tuberculosis 0.8%
Prophylaxis 0.8%
Systemic Antiviral Treatment 0.8%
Hiv Test Positive 0.6%
Antiviral Treatment 0.6%
Acquired Immunodeficiency Syndrome 0.5%
Depression 0.5%
Maternal Exposure During Pregnancy 0.5%
Hyperlipidaemia 0.4%
Burkitt's Lymphoma 0.4%
Mycobacterium Avium Complex Infection 0.4%
Routine Health Maintenance 0.4%
Abortion Spontaneous 11.5%
Haematotoxicity 9.1%
Abortion Induced 7.9%
Premature Baby 6.3%
Drug Interaction 5.9%
Rash 5.5%
Stillbirth 5.5%
Weight Decreased 5.1%
Death 4.7%
Drug Exposure During Pregnancy 4.3%
Foetal Exposure During Pregnancy 4.0%
Pneumonia 4.0%
Blood Bilirubin Increased 3.6%
Ventricular Septal Defect 3.6%
Arrhythmia 3.2%
Blood Bilirubin Unconjugated Increased 3.2%
Drug Resistance 3.2%
Haemolytic Anaemia 3.2%
Hepatic Enzyme Increased 3.2%
Vomiting 3.2%
Secondary
Hiv Infection 72.9%
Antiretroviral Therapy 3.8%
Product Used For Unknown Indication 3.5%
Drug Use For Unknown Indication 3.3%
Drug Exposure During Pregnancy 2.3%
Prophylaxis 2.0%
Hypertension 1.4%
Burkitt's Lymphoma 1.3%
Antifungal Prophylaxis 1.3%
Acquired Immunodeficiency Syndrome 1.2%
Depression 1.2%
Tuberculosis 1.2%
Hepatitis C 0.9%
Diabetes Mellitus 0.8%
Pneumocystis Jiroveci Pneumonia 0.6%
Asthma 0.5%
Insomnia 0.5%
Pyrexia 0.5%
Diarrhoea 0.5%
Medical Diet 0.4%
Renal Failure Acute 9.2%
Pregnancy 8.3%
Osteonecrosis 6.9%
Vomiting 6.3%
Weight Decreased 6.1%
Umbilical Cord Abnormality 6.0%
Myocardial Infarction 5.2%
Progressive External Ophthalmoplegia 5.0%
Nephrolithiasis 4.8%
Thrombocytopenia 4.5%
Weight Increased 4.3%
Immune Reconstitution Syndrome 4.1%
Pancreatitis 3.9%
Renal Failure 3.9%
Rhabdomyolysis 3.9%
Ventricular Hypertrophy 3.8%
Drug Interaction 3.6%
Premature Labour 3.5%
Abortion Spontaneous 3.4%
Pyrexia 3.4%
Concomitant
Hiv Infection 73.0%
Drug Use For Unknown Indication 5.4%
Product Used For Unknown Indication 3.3%
Acquired Immunodeficiency Syndrome 1.9%
Hepatitis C 1.8%
Antiretroviral Therapy 1.7%
Depression 1.4%
Prophylaxis 1.3%
Hypertension 1.3%
Drug Exposure During Pregnancy 1.2%
Burkitt's Lymphoma 1.1%
Antifungal Prophylaxis 0.8%
Diabetes Mellitus 0.8%
Hiv Test Positive 0.8%
Pain 0.8%
Pneumocystis Jiroveci Pneumonia 0.8%
Antibiotic Prophylaxis 0.7%
Prophylaxis Against Hiv Infection 0.7%
Diarrhoea 0.6%
Asthma 0.5%
Weight Decreased 10.1%
Vomiting 8.8%
Rash 7.4%
Rhabdomyolysis 6.1%
Drug Exposure During Pregnancy 6.0%
Myocardial Infarction 5.8%
Death 5.2%
Renal Failure Acute 5.2%
Thrombocytopenia 5.1%
Pyrexia 4.5%
Nephrolithiasis 4.3%
Renal Failure 4.0%
Renal Tubular Necrosis 4.0%
Pancreatitis 3.6%
Jaundice 3.4%
Premature Baby 3.4%
Small For Dates Baby 3.4%
Abortion Spontaneous 3.2%
Suicidal Ideation 3.2%
Hodgkin's Disease 3.1%
Interacting
Hiv Infection 55.3%
Antiretroviral Therapy 14.1%
Product Used For Unknown Indication 7.3%
Hypertension 4.0%
Neuropathy Peripheral 2.8%
Anxiety 1.6%
Blood Pressure Increased 1.5%
Depression 1.5%
Immunosuppressant Drug Therapy 1.5%
Alcohol Abuse 1.4%
Back Pain 1.1%
Herpes Simplex 1.1%
Drug Use For Unknown Indication 1.0%
Acquired Immunodeficiency Syndrome 0.9%
Bipolar Disorder 0.9%
Chronic Obstructive Pulmonary Disease 0.9%
Fungal Infection 0.9%
Splenectomy 0.9%
Asthma 0.8%
Colitis 0.8%
Drug Interaction 39.3%
Oedema Peripheral 7.4%
Cushing's Syndrome 4.9%
Weight Increased 4.9%
Toxicity To Various Agents 4.1%
Lactic Acidosis 3.3%
Overdose 3.3%
Renal Impairment 3.3%
Secondary Adrenocortical Insufficiency 3.3%
Vision Blurred 3.3%
Drug Level Increased 2.5%
Hepatobiliary Disease 2.5%
Hyperglycaemia 2.5%
Hypothyroidism 2.5%
Renal Tubular Necrosis 2.5%
Sedation 2.5%
Serotonin Syndrome 2.5%
Somnolence 2.5%
Blood Creatinine Increased 1.6%
Hepatitis B 1.6%